Capital Planning’s Eli Lilly LLY Stock Holding History

Capital Planning’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$477K	Hold	412	–	–	0.13%	58
2026 Q2	$494K	Buy	412 +1	+0.2%	+$1.02K	0.14%	55
2026 Q1	$378K	Hold	411	–	–	0.12%	60
2025 Q4	$444K	Buy	411 +1	+0.2%	+$956	0.12%	61
2025 Q3	$313K	Hold	410	–	–	0.09%	68
2025 Q2	$320K	Hold	410	–	–	0.1%	60
2025 Q1	$338K	Sell	410 -71	-15%	-$59.1K	0.09%	77
2024 Q4	$371K	Buy	481 +65	+16%	+$53.8K	0.1%	72
2024 Q3	$368K	Buy	416 +79	+23%	+$71K	0.1%	70
2024 Q2	$305K	Hold	337	–	–	0.09%	67
2024 Q1	$262K	Buy	+337	New	+$240K	0.09%	75

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Capital Planning's LLY Position: Q3 2026 in Review

Capital Planning held its Eli Lilly (LLY) position steady in Q3 2026 at 412 shares worth $477K. The position accounts for 0.13% of the portfolio, ranked #58.

Capital Planning first reported a position in LLY in Q1 2024 and has held it in 11 quarters since. The position peaked at $494K in Q2 2026. 1,995 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Capital Planning held 412 shares of Eli Lilly worth $477K as of Q3 2026.
Capital Planning left its Eli Lilly share count unchanged in Q3 2026.
Eli Lilly made up 0.13% of Capital Planning's portfolio in Q3 2026, its #58 holding.
Capital Planning first reported a position in Eli Lilly in Q1 2024 and has held it in 11 quarters since.
Capital Planning's Eli Lilly position peaked at $494K in Q2 2026.
1,995 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Capital Planning's 13F filing for Q3 2026, filed 9 Oct 2026.